Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma HL Kaufman, CE Ruby, T Hughes, CL Slingluff Journal for immunotherapy of cancer 2, 1-13, 2014 | 252 | 2014 |
Association of shared decision-making on patient-reported health outcomes and healthcare utilization TM Hughes, K Merath, Q Chen, S Sun, E Palmer, JJ Idrees, V Okunrintemi, ... The American Journal of Surgery 216 (1), 7-12, 2018 | 206 | 2018 |
Mutant HSP70 reverses autoimmune depigmentation in vitiligo JA Mosenson, A Zloza, JD Nieland, E Garrett-Mayer, JM Eby, ... Science translational medicine 5 (174), 174ra28-174ra28, 2013 | 127 | 2013 |
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade FJ Kohlhapp, JR Broucek, T Hughes, EJ Huelsmann, J Lusciks, JP Zayas, ... Journal for immunotherapy of cancer 3, 1-13, 2015 | 65 | 2015 |
Update on current problems in colorectal liver metastasis J Chakedis, MH Squires, EW Beal, T Hughes, H Lewis, A Paredes, ... Current problems in surgery 54 (11), 554-602, 2017 | 61 | 2017 |
Virus-positive Merkel cell carcinoma is an independent prognostic group with distinct predictive biomarkers KL Harms, L Zhao, B Johnson, X Wang, S Carskadon, N Palanisamy, ... Clinical Cancer Research 27 (9), 2494-2504, 2021 | 53 | 2021 |
Barriers and Facilitators to De-Implementation of the Choosing Wisely® Guidelines for Low-Value Breast Cancer Surgery ME Smith, CA Vitous, TM Hughes, SP Shubeck, R Jagsi, LA Dossett Annals of surgical oncology 27, 2653-2663, 2020 | 50 | 2020 |
Active surveillance of patients who have sentinel node positive melanoma: an international, multi‐institution evaluation of adoption and early outcomes after the Multicenter … KK Broman, T Hughes, L Dossett, J Sun, D Kirichenko, MJ Carr, A Sharma, ... Cancer 127 (13), 2251-2261, 2021 | 44 | 2021 |
The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma T Hughes, M Klairmont, J Broucek, G Iodice, S Basu, HL Kaufman Cancer Immunology, Immunotherapy 64, 459-465, 2015 | 43 | 2015 |
Interleukin-2, ipilimumab, and anti-PD-1: clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma T Hughes, M Klairmont, WH Sharfman, HL Kaufman Cancer biology & therapy 22 (10-12), 513-526, 2021 | 38 | 2021 |
Critical analysis of an oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor for the treatment of malignant melanoma T Hughes, RS Coffin, CE Lilley, R Ponce, HL Kaufman Oncolytic virotherapy, 11-20, 2014 | 34 | 2014 |
Recognizing heuristics and bias in clinical decision-making TM Hughes, LA Dossett, ST Hawley, DA Telem Annals of Surgery 271 (5), 813-814, 2020 | 28 | 2020 |
Non-oncogenic acute viral infections disrupt anti-cancer responses and lead to accelerated cancer-specific host death FJ Kohlhapp, EJ Huelsmann, AT Lacek, JM Schenkel, J Lusciks, ... Cell reports 17 (4), 957-965, 2016 | 27 | 2016 |
Trends in breast cancer treatment de-implementation in older patients with hormone receptor-positive breast cancer: a mixed methods study T Wang, A Baskin, J Miller, A Metz, N Matusko, T Hughes, M Sabel, ... Annals of surgical oncology 28, 902-913, 2021 | 25 | 2021 |
Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer: 13-year follow-up AE Onuma, EW Beal, F Nabhan, T Hughes, WB Farrar, J Phay, MD Ringel, ... Annals of surgical oncology 26, 1737-1743, 2019 | 21 | 2019 |
Surveillance of sentinel node-positive melanoma patients with reasons for exclusion from MSLT-II: multi-institutional propensity score matched analysis KK Broman, TM Hughes, LA Dossett, J Sun, MJ Carr, DA Kirichenko, ... Journal of the American College of Surgeons 232 (4), 424-431, 2021 | 19 | 2021 |
Letters of recommendation for surgical fellowships–Does gender make a difference? C Horwood, S McDermott, T Gennell, TM Pawlik, VP Grignol, TM Hughes The American Journal of Surgery 221 (1), 90-94, 2021 | 18 | 2021 |
Work hours and depression in US first-year physicians Y Fang, S Lodi, TM Hughes, E Frank, S Sen, ASB Bohnert New England Journal of Medicine 387 (16), 1522-1524, 2022 | 16 | 2022 |
Management of the positive sentinel lymph node in the post‐MSLT‐II era BC Bredbeck, E Mubarak, DG Zubieta, R Tesorero, AR Holmes, ... Journal of surgical oncology 122 (8), 1778-1784, 2020 | 15 | 2020 |
For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging? DS Dizon, A Restivo, M Lomme, N Charbonneau, L Brard, T Hughes, ... American journal of clinical oncology 31 (1), 39-42, 2008 | 15 | 2008 |